hormones of the GI system Flashcards

(47 cards)

1
Q

clear cells

A

produce amines and peptides

endocrine cells in this category

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

open configuration

A

most endocrine cells of gastroentero-pancreatic system, except for those in the pancreas and oxyntic region of the stomach
have both a luminal and serosal face
enables cells to be more easily affected by luminal factors
gives the cells the potential for exocrine as well as paracrine and endocrine functions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

families of GEP hormones

A

secretin and gastrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

peptides in secretin family

A

vasoactive intestinal polypeptide (VIP)
gastric inhibitory polypeptide (GIP)
pancreatic glucagon
gut glucagon-like immunoreactivity (GLP-1)
bombesin (aka gastrin releasing peptide (GRP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

bombesin (gastrin releasing peptide, GRP)

A

originally isolated in skin of amphibians

vagal transmitter that accounts for release of gastrin seen following vagal stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

peptides in gastrin family

A
gastrin
cholecytokinin (CCK)
motilin
enkephalin
cerulein (in amphibians)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GEP hormones that don’t fall into gastrin or secretin families

A
pancreatic polypeptide (PP)
somatostatin (SRIH)
uragastrone
chymodenin (also secretin)
tachydinins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

gastin family characteristics

A

size homology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

gastrin

A

in gastrin family
has 4 major forms in the circulation
largest form = component I = likely preprogastrin or part of gastrin precursor
big gastrin = 34 AA
this followed by 17 AA form and 14 AA form
each exists in sulfated and nonsulfated forms - doubles number of variants
total of 20 or more variants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

scheme proposed for purpose of multiple strains of gastrin

A

component 1 = preprogastrin
cleaved enzymatically in cells to 34 AA form = progastrin
cleavage of this gives 17 AA form - most active on molar basis
further cleavage => 14 aa form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pentagastrin

A

form of gastrin most often clinically known
synthetic pentapeptide containing C-terminal of gastrin, beta-alanine, and tertiary butyloxycarbonyl (tBOC = N-terminal blocking agent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cholecytokinin

A

has some size heterogenity
primary circulating form has 33 AA residues
39 AA molecule also exists
small fragment - c-terminal octadecapeptide - has most of its biological activity
may be neuronal and act as NT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what will diminish the activity of gastrin and CCK

A

deamidation of C-terminal residue

removal of sulfate groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

secretin

A

requires all of its 27 AA residues to maintain biological activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

major physiological roles of gastrin

A

1: stimulation of gastric acid from oxyntic cells - can lead to increased release of pepsinogen from chief cells
2: a trophic action on the mucosa of the stomach
3: stimulation of gastric motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

gastrin and gastric acid secretion (synergism)

A

works synergistically with AcH and histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ACH on gastric acid secretion

A

works synergistically with Ach

generated from vagal impulses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

histamine on gastric acid secretion

A

acts through type 2 histamine receptors
works synergistically with gastrin
can be blocked by cymetidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

cymetidine

A

blocks effects of histamine and acetylcholamine on oxyntic cells and so blocks gastric acid secretion
used to treat ulsers
but also blocks histamine type 2 receptors in brain

20
Q

control of release of gastrin

A

stimulated by peptide digestion products of food and by vagal activity
AA in chyme, especially Tryp, Phe, and Arg can also stimulate release
release inhibited by acid, secretin
gastrin action inhibited by cholecystokinin (CCK)

21
Q

vagal activity in gastrin release

A

produces transmitter GRP (gastrin releasing peptide/bombesin)
accounts for all vagus-stimulated gastrin release

22
Q

negative feedback for gastrin release

A

inhibited by acid
when pH outside antral mucosa falls below pH 3.5, gastrin release turned off
indirect mechanism through acid stimulated release of somatostatin

23
Q

atrophic gastritis

A

chronic decrease in the output or function of oxyntic cells

often have extremely high circulating levels of gastrin because negative feedback mechanism is missing

24
Q

zollinger-ellison syndrome (ZE)

A

gastrin hypersecretion from pancreatic islet tumors (gastrinomas) or from hyperplastic mucosal G cells
results in gastric acid hypersecretion and ulcerative disease
also excessive overgrowth of gastric mucosa => additional acid production
diagnostic test: when secretin administered to patient with Z-E syndrome, causes increase in circulating gastrin levels - should inhibit

25
physiological effects of cholecystokinin (CCK)
1: stimulation of pancreatic proenzyme release 2: contraction of the gall bladder 3: relaxation of the sphincter of oddi 4: reduction of gastrin-induced acid secretion by competitive inhibition 5: important synergistic action with secretin on release of pancreatic HCO3-/H2O release
26
release of cholecystokinin (CCK)
major factors: peptides and certain AA from digestion of foods most potent stimulators = tryptophan and phenylalanine others = maline, leucine, and methionine fats and acidity weak stimulators
27
targets of cholesystokinin (CCK)
acts directly on acinar cells of the pancreas and on the muscle of the gall bladder effects on intestinal muscle mediated through release of AcH
28
what can CCK be used to diagnose?
pancreatic and gall bladder disease stimulatory effects on intestinal muscle used in roentgenological investigations of the intestine has limited applicability theraputically but can be used to eliminate obstructions from the bile duct without surgery
29
physiological roles of secretin
1: stimulation of pancreatic water and bicarbonate secretion into the duodenum - synergizes with CCK 2: inhibits acid secretion by gastrin by inhibiting the release of this peptide 3: acts synergistically with CCK in promoting release of pancreatic enzymes, flow of bile, and the composition of bile (increases H2O/HCO3- content)
30
release of secretin
stimulated by the introduction of acid into the upper small intestine not dependent on neuronal innervation but its action on the pancres are reduced by vagotomy
31
use of secretin in diagnosis
in examination of pancreatic function | for zollinger-ellison syndrome
32
glucagon-like peptide I (GLP-1)
most potent stimulator of insulin release from the pancreas, esp. in response to orally ingested glucose intake of glucose increases release of GLP-1 => increased insulin levels in the protal blood system before glucose blood levels rise appreciably inhibits gastric secretion and emptying
33
glucagon-like peptide 1 structure and synthesis
30 AA peptide | produced by intestinal L cells
34
use of GLP1 clinically
anorexogenic | used to treat patients with T2DM
35
ghrelin
28 AA elevated in blood during fasting and insulin-induced hypoglycemia same as brain/gut peptide growth hormone releasing peptide (GHRP) = stimulates GH release by increasing GHRH release, inhibiting somatostatin release, and having a direct positive effect on somatotrophs in the pituitary
36
leptin
protein hormone of adipose tissue - involved in energy balance activates cell-surface receptors to inhibit the desire to eat = anorexogenic
37
adiponectin
protein hormone of adipose tissue - involved in energy balance activates cell-surface receptors to inhibit the desire to eat = anorexogenic increases insulin responsiveness in T2DM
38
vasoactive intestinal peptide (VIP)
major mode of action may be as a NT as GI hormone: released by dilute HCl or fat introduced into duodenum acts with NO in producing sphincter relaxation can also inhibit gastric acid secretion and motility, inhibit gall bladder contraction, and stimulate water and electrolyte secretion from mucosal surfaces of the intestine and pancreas tumors that secrete VIP in large amounts (VIPomas) associated with watery-diarrhea syndrome - indirectly supports an effect on mucosal secretion of water and electrolytes
39
gastric inhibitory peptide (GIP)
inhibitory effect on gastric acid secretion, pepsin secretion, gastric motor activity - but questions about this has role in control of insulin secretion (though not as potent as GLP-1) when exogenously administered, causes increase in circulating insulin level insulinotropic effect seems directly related to level of plasma glucose not insulinotropic in presence of basal plasma glucose levels, but intravenous infusion or ingestion of gucose increase circulating levels of immunoreactive GIP release also stimulated by duodenal perfusion of an AA mixture gastrin and CCK seem to potentiate this
40
somatostatin
hypothalamic peptide - NT in peripheral and CNS GH release inhibiting product of D-cells of pancreatic islets and gastric mucosa inhibits insulin and glucagon release and secretion of gastric acid and release of gastrin, secretin, CCK, GIP, VIP and motilin release in stomach sensitive to acid in chime and plays a pivotal role in neg feedback control of gastrin release
41
urogastrone
epidermal growth factor has been located to submaxillary glands adn brunner's glands of duodenum potent inhibitor of acid secretion
42
enkephalin
immunoreactive in antral stomach, duodenum, ileum, colon, gall bladder, and pancreas opiate appears to be generally inhibitory
43
peptide YY
36 AA, 18 identical to pancreatic polypeptide, tyrosine residues at amino- and carboxyl- terminals fat stimulates release inhibits gastric secretion and emptying - vagal effects
44
peptides of amphibian skin
includes: bombesin-like peptides, cerulein, tachykinins
45
bonbesin-like peptides
in stomach and upper small intestine of mammals in category of "peptides of amphibian skin" biological activities identical to bombesin peptides of amphibian skin include stimulation of gastric acid, pepsin, gastrin, pancreatic enzymes, and pancreatid peptide inhibition of gastric and duodenal motility bonbesin is gastrin-releaseing hormone (GRP) and completely accounts for bagally stimulated gastrin release
46
tachykinins
in category of peptides of amphibian skin resemble substance P of mammals both in structure and activity stimulate GI motility and exocrine secretions of the pancreas
47
cerulein
on category of peptides of amphibian skin close resemblance with regards to chemical structure to gastrin family stimulates gastric motility, exocrine secretions of stomach and pancreas, and release of insulin, glucagon, calcitonin, and pancreatic polypeptide